Issue 3, 2018

Nanofiber membrane supported lung-on-a-chip microdevice for anti-cancer drug testing

Abstract

Organ-on-a-chip technology can simulate the physiological and pathological microenvironment of tissues and organs in vitro, thus offering the potential of dispensing with animal models to predict the toxicity and efficacy of therapies. In this study, taking the alveolar microenvironment as a model, we developed a lung-on-a-chip with a poly(lactic-co-glycolic acid) (PLGA) electrospinning nanofiber membrane as the chip substrate and cell scaffold. The PLGA nanofiber membrane, with a controlled thickness of ∼3 μm, is porous and permeable to molecules, has good biocompatibility, and offers a means to simulate the alveolar respiratory membrane. On the chip, we carried out cell culture and co-culture of human non-small cell lung cancer cells (A549) and human fetal lung fibroblasts (HFL1), and evaluated gefitinib, an epidermal growth factor receptor (EGFR)-targeted anti-tumor drug. We further probed the possible sources of A549 cell drug resistance in the presence of HFL1 cells. In addition, we co-cultured A549, HFL1, and human umbilical vein endothelial cells (HUVECs), and found that A549 cells could lead to endothelial cell apoptosis or death, and then the occurrence of tumor invasion. This established lung-on-a-chip is simple, effective, and easy to operate. It is expected to have important applications in personalized treatment of lung tumors and to play a potential role in other clinical treatments and tissue engineering.

Graphical abstract: Nanofiber membrane supported lung-on-a-chip microdevice for anti-cancer drug testing

Supplementary files

Article information

Article type
Paper
Submitted
16 Huk 2017
Accepted
31 N’w 2017
First published
03 Sun 2018

Lab Chip, 2018,18, 486-495

Nanofiber membrane supported lung-on-a-chip microdevice for anti-cancer drug testing

X. Yang, K. Li, X. Zhang, C. Liu, B. Guo, W. Wen and X. Gao, Lab Chip, 2018, 18, 486 DOI: 10.1039/C7LC01224A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements